Archived
6505--Ustekinumab Pens/Syringes or Biosimilar
Overview
- Response deadline
- 2:30 PM CST
- Posted
- February 6, 2026
- Notice type
- Solicitation
Notice details
- Office
- NAC PHARMACEUTICALS (36E797)
- Last updated
- Nov 3, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36E79726R0006
- Notice ID
- 1fad539d56c041da866be428416e766b
Description
Extend due date.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Christopher Carthron
Contract Specialist
Documents
Lifecycle
- 1Version 1SolicitationArchived
6505--Ustekinumab Pens/Syringes or Biosimilar
- 2Version 2SolicitationArchived
6505--Ustekinumab Pens/Syringes or Biosimilar
- 4Version 4SolicitationArchivedCurrent
6505--Ustekinumab Pens/Syringes or Biosimilar
Other notices for this solicitation
- Pre-SolicitationRelated noticeDec 11, 2025
6505--Ustekinumab Pens/Syringes or Biosimilar
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79726R0006
Archive Date
Mar 12, 2026
Office Address
HINES, IL, 60141